Nils Lonberg, a Ph.D. from Harvard, was a revolutionary scientist who made groundbreaking contributions to cancer research. In the book The Elegant Defense, author Matt Richtel outlines how “for centuries, the fight against cancer had been built on the idea of attacking the cancer,” but Lonberg leveraged the fact that cancer gets out of control because the immune system receives “a signal to stop from the cancer,” and thinks the signal is legitimate. He focused on targeting how the cancer interacted with the immune system, and his work was published in the 2007 New England Journal of Medicine.
Article Link: Building Enterprise Immunity with XDR